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The genus Streptomyces comprises Gram-positive, soil-dwelling, filamentous bacteria. It shows complex morphological differentiation resembling that of filamentous fungi, which makes this genus a model prokaryote for the study of multicellular differentiation. On agar medium, one or more substrate hyphae formed from a germinating spore branch frequently and grow rapidly by cell wall extention at the hyphal tips. Subsequently aerial hyphae emerge by reuse of material assimilated into the substrate mycelium, such as DNA, proteins, and storage compounds. Many cells in substrate hyphae thus lyse and die. When apical growth of aerial hyphae stops, in contrast to substrate mycelium, septa are formed at regular intervals along the hyphae to form many unigenomic compartments within a sheath composed of elongated hollow or grooved elements, finer fibrillar elements, and amorphous material. The sporulation septa consist of two membrane layers separated by a double layer of cell-wall material, which permits the eventual separation of adjacent spores. Spore chains usually consist of many tens of spores. The aerial spores thus formed are resistant to heat-treatment and lysozyme-digestion. Streptomyces strains have hence been called ''boundary organisms'' between prokaryotes and eukaryotes.
Another characteristic of the genus Streptomyces is the ability to produce a wide variety of secondary metabolites, including antibiotics and biologically active substances. Secondary metabolism is sometimes termed ''physiological'' differentiation because it occurs during the idiophase after the main period of rapid vegetative growth and assimilative metabolism. Because of the ability to produce a wide variety not only of secondary metabolites, such as antibiotics, immunosuppressants, and enzyme inhibitors, but also of industrially important enzymes, such as glucose isomerase and transglutaminase, Streptomyces has contributed much to the worldleading fermentation industry in Japan. In addition, a variety of enzymes for secondary metabolite formation have become members of artificial gene clusters for the biosynthesis of novel compounds by so-called combinatorial biosynthesis.
Morphological development and secondary metabolism are simultaneously under the control of various nutritional environments, such as carbon, nitrogen, and phosphorous nutrients, and trace elements. Chemical signaling molecules having a -butyrolactone ring also control both morphological and physiological differentiation of Streptomyces spp. The pioneer work of Khokhlov et al. 1) on an autoregulatory factor (A-factor, 2-isocapryloyl-3R-hydroxymethyl--butyrolactone; see Fig. 1 for chemical structure), which induces both sporulation and streptomycin biosynthesis in a mutant of Streptomyces griseus, revealed an exact link between secondary metabolism and morphological differentiation. Subsequent studies from several laboratories have indicated that A-factor and its derivatives in various Streptomyces spp. are actually autoregulators or microbial hormones that switch on morphological differentiation or secondary metabolism, or both. [2] [3] [4] [5] [6] Studies of A-factor over more than 25 years at the Laboratory of Fermentation and Microbiology, The University of Tokyo have established that it can be termed a microbial hormone that switches on morphological and physiological differentiation with specific timing by monitoring the physiological conditions of the cell. [7] [8] [9] In addition to hormonal control by A-factor, serine/ threonine kinases also control secondary metabolism and morphogenesis. A representative of the serine/ threonine kinases is AfsK, which activates the DNAbinding activity of a transcriptional factor AfsR by phosphorylating its threonine residue. 10, 11) Cyclic-AMP that is biosynthesized by a eukaryotic-type adenylcyclase 12) and a calmodulin-like protein 13) are also involved in morphological differentiation. Therefore, Streptomyces members are boundary organisms from the viewpoint not only of their morphogenesis but also of gene regulatory systems.
This review article summarizes the study of the biology and chemistry of Streptomyces at this laboratory, on the occasion of an award I have received from the Japan Society for Bioscience, Biotechnology, and Agrochemistry. I summarize study of (i) the A-factor regulatory cascade that leads to aerial mycelium formation and secondary metabolite formation in S. griseus, (ii) the AfsK/AfsR/AfsS system, which controls both secondary metabolism and morphogenesis, and (iii) the catalytic properties of certain enzymes involved in secondary metabolism, and (iv) application of Streptomyces enzymes in fermentative production of natural and unnatural flavonoids by combinatorial biosynthesis.
I. The A-Factor Regulatory Cascade
The strain we have studied is a historical one, S. griseus IFO13350 (= ISP5236; Streptomyces griseus subsp. griseus, Waksman and Henrici 1948), which was discovered by Selman A. Waksman as a streptomycinproducer. The strain Khokhlov studied appears to be the same as the Waksman's strain. 2, 3) Figure 1 illustrates the A-factor regulatory cascade we so far have identified 7, 8) for the historical strain that won the Nobel Prize for Waksman. In S. griseus, A-factor is gradually accumulated in a growth-dependent manner by the activity of AfsA, which catalyzes -ketoacyl transfer between a glycerol derivative and a -keto acid. When the concentration of A-factor reaches a critical level at or near the middle of exponential growth, it binds the Afactor receptor protein (ArpA), which has bound and repressed the promoter of a gene encoding a key transcriptional factor (AdpA), and dissociates ArpA from the promoter, leading to transcription and trans- The A-factor signal, starting with the A-factor biosynthesis gene afsA, is transferred to the receptor ArpA, to a transcriptional activator AdpA, and finally to a variety of genes required for morphological development and secondary metabolite formation. 7, 8) See the text for details of the target genes of AdpA. Through this cascade, morphological and physiological differentiation occurs at a specific time of growth, when the intracellular concentration reaches a critical level at or near the middle of the exponential growth. Reproduced in modified form from Ohnishi and Horinouchi. 8) lation of adpA. AdpA then activates a variety of genes of various functions that are required for secondary metabolism and morphological development. One of the targets of AdpA is strR, encoding the pathwayspecific transcriptional factor for the streptomycin biosynthesis genes. Thus, the A-factor signal is transferred to the streptomycin biosynthesis genes, starting with AfsA, then to ArpA to AdpA to StrR, and finally to all the streptomycin biosynthetic genes, causing the onset of streptomycin biosynthesis. Khokhlov's discovery forty years ago of a mysterious link between Afactor and streptomycin production has thus been explained at the molecular level.
Properties of A-factor and its homologs in actinomycetes
A-factor was originally discovered by Khokhlov and coworkers 1) in the culture broth of S. griseus as a factor that induced streptomycin production and aerial mycelium formation in a mutant strain of S. griseus. The genetic study of A-factor biosynthesis by Hara and Beppu 14, 15) in this laboratory confirmed their observations, and revealed that chemically synthesized, optically active A-factor, provided by Mori 16) in the same department, restores all the phenotypic defects of Afactor-deficient mutant strain HH1 at concentrations as low as 10 À9 M. Subsequent studies showed that A-factor also controls the production of a yellow pigment and a melanin-like pigment, in addition to streptomycin. 2) Study of the yellow pigment, grixazone, and the melanin-like pigment, hexahydroxyperylenequinone, has led to fruitful discoveries of novel enzymes responsible for the biosynthesis of these pigments, as described below.
A-factor-deficient mutants, like mutant HH1, were readily obtained by treatment of the wild-type strain by UV irradiation or incubation at 32 C. 14) The extreme instability of A-factor productivity was later explained in terms of the location of afsA, a gene encoding a key A-factor biosynthesis enzyme, AfsA, 17, 18) which is located in the vicinity of one end of the linear chromosome.
19) The ends of the Streptomyces chromosomes are deleted at high frequency due to homologous recombination between a long repeat sequence on both ends of the linear chromosome. The genome sequence of S. griseus in a total of 8,545,929 bp (Y. Ohnishi et al., manuscript in preparation) shows that afsA is located 272 kb from one end of the chromosome.
A-factor homologs having a -butyrolactone structure have been found in various Streptomyces species, such as S. bikiniensis, S. coelicolor A3(2), S. cyaneofuscatus, S. lavendulae, S. virginiae, and S. viridochromogenes (reviewed in Refs. 3 and 7). Virginiae butanolides (VBs) controlling virginiamycin production in S. virginiae, 20) IM-2 controlling pigment production in S. lavendulae, 21) and SCB1 controlling actinorhodin and undecylprodigiosin production in S. coelicolor A3(2) 22) are examples. These strains contain homologs of afsA, encoding a key A-factor biosynthesis enzyme, and arpA, encoding the A-factor receptor, which implies that the mechanism of regulation by these -butyrolactones is the same as that for the A-factor regulatory system including afsA and arpA.
The -butyrolactone-type autoregulators produced at a portion of a hypha in response to certain environmental stimuli can move freely within the individual hypha and spread into neighboring hyphae. Due to filamentous growth, Streptomyces have developed diffusible -butyrolactone regulatory systems that facilitate communication between the cells at a distance within an individual hypha and between different hyphae. The filamentous mycelia of Streptomyces are close enough to communicate with one another. The signaling system between physically separate individual cells in the same mycelium can be termed hormonal regulation, as opposed to the quorum sensing found in Gram-negative single-cell bacteria growing in liquid culture. 23, 24) However, A-factor is also important in cell-to-cell communication between neighboring mycelia, similarly to the quorum sensing system. Since a given Streptomyces strain contains its own -butyrolactone and its receptor with strict ligand specificity, this system also facilitates discrimination of signals originating from neighboring living things, thus allowing the cell to recognize the neighbor as a member of the same species or not. This system is also advantageous to survival in the ecosystem; A-factor produced by a cell is accepted by several hyphae and causes rapid sporulation of a whole population, which is advantageous, as compared with piecemeal sporulation of individual hyphae induced by environmental stimuli such as nutritional limitation.
The A-factor and receptor system in S. griseus acts as an all-or-nothing switch (i.e., a crucial switch) for both morphological and physiological differentiation. CprA and CprB, both of which are A-factor receptor homologs, act as tuners for these processes in S. coelicolor A3 (2) . 25) On the other hand, the VB system in S. virginiae also controls the timing of antibiotic production but not morphological development. These observations imply that Streptomyces has evolved the -butyrolactone regulatory system to control different steps in the regulatory hierarchy for healthy growth, as an all-ornothing switch for some phenotypes and simply as a tuner for other phenotypes. That may be why a Streptomyces strain contains redundant -butyrolactone regulatory systems.
Biosynthesis of A-factor
Concerning the A-factor biosynthesis enzymes, we proposed that AfsA was a key A-factor biosynthesis enzyme, because (i) afsA mutants lost A-factor productivity, 14, 17) (ii) introduction of afsA into A-factor nonproducing Streptomyces strains caused overproduction of A-factor with a gene dosage effect, 17) and (iii) introduction of afsA into Escherichia coli caused the host to produce a substance having A-factor activity. 26) Concerning the biosynthesis pathway, Sakuda et al. 27) proposed a route on the basis of feeding experiments in virginiae butanolide-producing Streptomyces antibioticus (pathways A and B in Fig. 2 ). According to their proposal, the skeleton is formed by coupling between a 3-carbon (C 3 ) unit derived from glycerol and a C 10 -keto acid derivative. Structure modeling of AfsA by S. Nakamura (unpublished data) in this department showed that, like -hydroxyacyl acyl carrier protein (ACP) dehydratase, AfsA has a tunnel that can accept an acyl chain of acyl-ACP. The presence of such a tunnel in AfsA supported the idea that AfsA is involved in Afactor biosynthesis at a step of condensation of a C 3 compound and a C 10 fatty acid derivative containing a -ketoacyl chain. On the basis of this information, Kato 28) has elucidated the A-factor biosynthesis pathway.
In vivo A-factor synthesis by E. coli carrying afsA alone. E. coli carrying afsA produces two new substances that are absent in the broth of E. coli without afsA, with their m=z 241 and 213 and the same MS/MS fragmentation pattern as A-factor. 26, 28) Because the culture broth shows A-factor activity and because E. coli does not produce branched fatty acids, we assume that these substances are A-factor analogs with a C 10 straight side chain (m=z 241) and a C 8 straight side chain (m=z 213).
In vitro synthesis of A-factor. Since the fatty acids of Streptomyces consist primarily of branched-chain fatty acids that are synthesized from isobutyryl-and methylbutyryl-coenzyme A (CoA), the C 10 branched side chain of A-factor is probably synthesized by condensation of isobutyryl-CoA and three acetate units. Kato et al. 28) revealed that AfsA catalyzes acyl transfer between 8-methyl-3-oxononanoyl-N-acetylcysteamine (NAC), a mimic of the corresponding -ketoacyl-ACP, and the hydroxyl group of dihydroxyacetone phosphate (DHAP) (Fig. 2) . The fatty acid ester produced is non-enzymatically converted to a butenolide phosphate by intramolecular aldol condensation. The butenolide phosphate is then reduced by the bprA product encoded just downstream of afsA. The stereoselectivity, the R-form, at position 3 is determined by this reduction step. The phosphate group on the resulting butanolide is finally removed by a phosphatase, resulting in the formation of A-factor. Kato 28) also confirmed that the 8-methyl-3-oxononanoyl-DHAP ester produced by the action of AfsA is converted to A-factor in an alternative way (pathway A) proposed by Sakuda et al.
27) The phosphate group on the ester is first removed by a phosphatase and the dephosphorylated ester is converted non-enzymatically to a butenolide, which is then reduced by a reductase different from BprA, resulting in A-factor. Because the introduction of afsA alone into Escherichia coli causes the host to produce a substance having Afactor activity, the reductases and phosphatases are not specific to the A-factor biosynthesis, but are commonly present in bacteria. AfsA is thus the key enzyme for the biosynthesis of -butyrolactones.
Structural variety of -butyrolactones. There are two structural differences in the -butyrolactone signal molecules in Streptomyces; one is the length and branching of the fatty acid side chain and the other is the reduction state of the 6-oxo group. The difference in side chain can be ascribed to the variety of theketoacyl-ACPs used by AfsA and its homologs. SCB1 in S. coelicolor A3(2), 22) having the same C 10 branched side chain as A-factor, should be formed by ScbA (AfsA ortholog) from the same -ketoacyl-ACP as for A-factor biosynthesis. The difference at position 6, either a keto or a hydroxyl group, can be ascribed to the existence and stereoselectivity of the reductase that reduces this AfsA catalyzes the condensation of DHAP and a -keto acid derivative. 28) After this condensation step, there are two biosynthesis routes to A-factor. Pathway A: A phosphate group is removed by a phosphatase, followed by non-enzymatic intramolecular aldol condensation. A C=C double bond is reduced by an NAD(P)Hdependent reductase, resulting in A-factor formation. Pathway B: Non-enzymatic intramolecular condensation of the ester, yielding a butenolide, is followed by a C=C double bond reduction step catalyzed by BprA. The last dephosphorylation step yields A-factor. position. Due to the absence of such reductases in S. griseus, position 6 of A-factor remains as a keto group. On the other hand, VBs in S. virginiae and SCB1 in S. coelicolor A3(2) have a hydroxyl group at position 6. BarS1 in S. virginiae is an NADPH-dependent reductase that reduces the 6-oxo group of the penultimate intermediate in VB biosynthesis.
29)
Regulation of A-factor biosynthesis. A-factor is accumulated in a growth-dependent manner and reaches a maximum, 25 to 30 ng/ml (about 100 nM), at or near the middle of exponential growth. 30) How is A-factor biosynthesis in such an extremely small amount controlled during growth? The transcription of afsA, starting at two points, is almost constant throughout growth. 28) Therefore, it is most likely that the time-course of Afactor production at this extremely low concentration is due to the availability of the substrates for AfsA. The concentration of DHAP, derived from glycolysis, depends on the physiological state. 8-Methyl-3-oxononanoyl-ACP, which is synthesized by condensation of three acetate units with the starter substrate isobutyrylCoA, is an intermediate in primary fatty acid biosynthesis, and is leaked from the pathway. Therefore, the intracellular pool of the -keto acid derivatives must be extremely small. Both glycolysis and fatty acid synthesis are active during exponential growth, and this is reflected on the time-course of A-factor production. Afactor that is synthesized from DHAP and 8-methyl-3-oxononanoyl-ACP via the -ketoacyl transfer activity of AfsA functions as a transmitter that monitors the biochemical and physiological state of the cell through the primary metabolites, leading to activation of the genes required for secondary metabolism and morphological differentiation. Biosynthesis of -butyrolactones reflective of the physiological conditions of Streptomyces is analogous to that of N-acylhomoserine lactones in Gram-negative bacteria; N-acylhomoserine lactones are biosynthesized from S-adenosylmethionine derived from the amino acid biosynthesis pathway and diverse intermediates in fatty acid biosynthesis. 31) 3. ArpA, the A-factor receptor protein Identification of ArpA. Miyake 32, 33) detected A-factorbinding activity in the cytoplasmic fraction of S. griseus using [
3 H]A-factor, and determined its repressor function as to streptomycin production and aerial mycelium formation by genetic studies. Onaka 34, 35) then cloned an A-factor receptor gene named arpA and determined the DNA-binding activity of ArpA and a consensus ArpAbinding sequence. The consensus ArpA-binding sequence determined was a 22-bp palindromic site with the sequence 5
as one half of the palindrome. ArpA binds this site in the absence of A-factor, and the exogenous addition of Afactor to the ArpA-DNA complex induces immediate release of ArpA from the DNA. These observations led to the idea that ArpA acts as a repressor-type regulator for secondary metabolism and morphological differentiation by preventing the expression of a certain key gene(s) during the early growth phase. A-factor, produced in a growth-dependent manner, releases ArpA from the DNA, thus switching on the expression of key genes, leading to the simultaneous onset of secondary metabolism and morphogenesis at a certain time during growth. Kato and Miyahisa 36) later identified adpA as the sole target of ArpA.
Site-directed mutagenesis of the helix-turn-helix DNA-binding motif of ArpA yielded a mutant ArpA protein (Val41Ala) that lacks DNA-binding ability but still retains the A-factor-binding ability. 37) Conversely, mutant Pro115Ser lacks the A-factor-binding ability but retains DNA-binding ability. 38) Mutant Trp119Ala also lacks A-factor-binding ability but retains DNA-binding ability, indicating that Trp-119 is essential for A-factor binding. 37) These findings show that ArpA contains two independently functional domains, a DNA-binding and an A-factor-binding domains.
Crystallography of -butyrolactone receptors. We attempted to analyze ArpA by X-ray crystallography. ArpA readily aggregated and our repeated attempts to obtain a crystal of ArpA failed. Next we tried to crystallize CprB, an ArpA homolog in S. coelicolor A3(2). 25) CprB, consisting of 215 amino acids, shows about 30% identity in amino acid sequence to ArpA. Although the ligand of CprB is still unknown, it recognizes and binds the same nucleotide sequence as ArpA. 37) In addition, CprB serves as a negative regulator for both morphological differentiation and secondary metabolism in S. coelicolor A3(2), as ArpA does in S. griseus. The crystal structures of two different forms were determined at 2.4 Å resolution by Natsume, 39) and they turned out to be a dimer with an shape (Fig. 3) . The DNA-binding domain is composed of three Nterminal helices, 1, 2, and 3. Of the three, 2 and 3 form a typical helix-turn-helix motif. Consistently with the observation that -butyrolactone receptors recognize the same nucleotide sequence, the residues on helix 3 are completely conserved among the receptors.
Ligand-binding pocket. A large cavity is present in the regulatory domain, which appears to be a ligand-binding pocket 5 Å in diameter and 20 Å long. Trp-127, corresponding to Trp-119 of ArpA, which has been found to be essential for A-factor binding by sitedirected mutagenesis, 37) participates in forming the pocket. The pocket is completely embedded in the molecule and a flexible loop covers the entrance to it, serving as a lid for it.
How A-factor dissociates receptor from DNA. A database search for structural comparison revealed that the overall structure of CprB is similar to those of the TetR family proteins, TetR and QacR. Hence we can predict how -butyrolactones dissociate their cognate receptors from DNA upon binding the ligands, on the basis of the mechanism of the conformational changes of TetR upon tetracycline binding. 40, 41) Ligand binding induces the relocation of a long helix 4 that links the ligand binding pocket with the DNA-binding domain. As a result of the relocation of the DNA-binding domain, ArpA dissociates from the DNA.
4. AdpA, a key transcriptional activator in the Afactor regulatory cascade Identification of AdpA. A study by Vujaklija 42, 43) on the transcriptional organization of part of the streptomycin biosynthetic gene cluster showed that one mRNA species covering a regulatory gene (strR) and the streptomycin-6-phosphotransferase (aphD) gene is dependent on A-factor. Intensive work by Ohnishi 44) led to identification of an A-factor-responsive protein (AdpA) able to bind the upstream activation sequence, about 270 bp upstream of the transcriptional start point of strR. AdpA, encoding a 405-amino-acid protein with a helixturn-helix DNA-binding motif at the central portion, showed sequence similarity to transcriptional regulators belonging to the AraC/XylS family. The À35 and À10 regions of adpA contained a 22 bp palindrome, caggcAGGAACGGACC Ã GCGCGGTACGCt (underlining indicates the À35 and À10 promoter elements, and Ã indicates a dyad axis), which showed similarity to the consensus sequence of the ArpA-binding site,
As expected, ArpA bound the promoter region of adpA in the absence of A-factor, but not in the presence of A-factor. In addition, exogenous addition of A-factor to the ArpA-DNA complex immediately dissociated ArpA from the DNA. Thus the promoter of adpA turned out to be a target of ArpA. Consistent with this, S1 nuclease mapping showed that adpA is transcribed only in the presence of A-factor and that strR is transcribed only in the presence of intact adpA. Furthermore, adpA disruptants produced no streptomycin, and overexpression of adpA caused the wild-type S. griseus strain to produce streptomycin at an earlier growth stage and in larger amounts. adpA as a single target of ArpA. Because ArpA acts as a repressor of aerial mycelium formation and secondary metabolism, an arpA disruptant forms aerial hyphae and spores earlier than the wild-type strain and overproduces streptomycin and other secondary metabolites. On the other hand, mutant KM2, expressing a mutant ArpA (Trp119Ala), neither produces secondary metabolites nor forms aerial hyphae, since this A-factorinsensitive mutant ArpA always binds to and represses the adpA promoter. Trp-119 of ArpA is essential for Afactor binding, and replacement of this Trp residue with Ala abolishes its A-factor-binding ability, resulting in The -butyrolactone receptors constitute a dimer, each subunit of which contains a ligand-binding pocket in the C-terminal portion. 39) The receptor dimer binds the same face of the DNA by inserting the DNA-binding helices in the major groove. The A-factor molecule in the pocket is illustrated with a ball model. The binding of A-factor so that it is embedded completely in the pocket relocates the DNA-binding domains (DBD) outside the molecule via the long helix-4, thus dissociating ArpA from the DNA. This computer-modeled structure was provided by R. Natsume. 39) the formation of a mutant ArpA that binds the target DNA irrespective of the presence of A-factor. 37) When adpA under the control of a foreign, constitutively expressed promoter is introduced into mutant KM2, all the phenotypes that we can observe are restored. 36) Hence we can conclude that the only significant target of ArpA is adpA.
Autorepression of adpA. The intracellular concentration of AdpA must be important for ordered gene expression for healthy growth. Consistent with this idea, Kato 45) found that AdpA represses its own transcription by forming a DNA loop via two molecules of AdpA dimer that bind the operator sites in the adpA promoter. Thus AdpA self-controls the intracellular concentration at an appropriate level by cooperatively binding to the two operator sites, allowing effective regulation to result from small alterations in the AdpA concentration and serving as a fine sensor of the AdpA concentration.
AdpA regulon. For isolation of targets of AdpA by gel mobility shift assay in a combination with immunoprecipitation and PCR, Yamazaki 46) collected more than 60 DNA fragments that were specifically bound by AdpA. The presence of many genes, all of which are simultaneously activated by AdpA at a specific point in the growth phase, means that the signal from A-factor is greatly amplified at this regulatory step via AdpA as an amplifier (Fig. 1) . The targets of AdpA required for morphological differentiation are the following: adsA, encoding an extracytoplasmic function (ECF) factor; 46) amfR, encoding a transcriptional factor that activates the amf operon; 47, 48) extracellular proteases, including a metalloendopeptidase, 49) two trypsin-type proteases, 50) and three chymotrypsin-type proteases; 51) a Streptomyces subtilisin inhibitor (SSI) gene; 52) and ssgA, which is essential for spore septum formation.
53) The Afactor-dependent proteases in conjunction with the SSI are supposed to control aerial mycelium formation, since Streptomyces forms aerial hyphae by reuse of material assimilated in substrate hyphae by ''apoptosis'' or ''cannibalism.'' The amf operon is for production of a hydrophobin, AmfS, that is essential for the erection of aerial hyphae into the air. 54, 55) For secondary metabolism, AdpA indirectly activates griR, a pathway-specific transcriptional activator for grixazone production (T. Higashi et al., manuscript in preparation) and a gene encoding a transcriptional factor probably for biosynthesis of a polyketide compound, 56) in addition to strR for streptomycin production.
57)
Open complex formation. For activation of target genes, a dimer of AdpA binds various positions, for example more than 200 bp upstream and 25 bp downstream of their transcriptional start points. [47] [48] [49] In addition, AdpA binds a single site for activation of certain genes and two or three sites for others. For transcriptional activation, some genes require simultaneous binding of a dimer of AdpA to multiple sites. 48, 49) Despite the differences in binding position and number of binding sites, AdpA recruits RNA polymerase to the specific promoter region of the target genes and facilitates isomerization of the RNA polymerase-DNA complex into an open complex for transcriptional initiation, 48, 56) as found for other transcriptional activators.
Consensus AdpA-binding sequence. Alignment of more than 10 AdpA-binding sequences, which were determined by DNase I footprinting, did not predict an apparent consensus sequence for AdpA binding. Yamazaki 56) performed interference assays on several AdpA-binding sites to determine the nucleotides directly associated with amino acids of AdpA and deduced a consensus AdpA-binding sequence, 5
0 -TGGCSNGW-WY-3 0 (S: G or C; W: A or T; Y: T or C; N: any nucleotide). The AdpA-binding sites so far identified all contain a sequence similar to this consensus sequence. Among the consensus sequence, the 4th C is essential for AdpA binding, and replacement of this C residue with other nucleotides results in abolishment of AdpA binding. In addition to the consensus sequence of 10 nucleotides, additional eight nucleotides 3 0 to this sequence also contribute to the affinity of AdpA, although there is no sequence conservation in this region.
5. How A-factor triggers streptomycin production strR, encoding the pathway-specific transcriptional activator for all the streptomycin biosynthesis genes, is a member of the AdpA regulon. The signal relay from Afactor to the streptomycin biosynthetic genes is from afsA to arpA to adpA to strR to the streptomycin production genes. A-factor produced by the action of AfsA in a growth-dependent manner binds ArpA that has bound and repressed the promoter of adpA at an early growth stage. When the concentration of A-factor reaches a critical level, it binds the DNA-bound ArpA and dissociates ArpA from the DNA, thus causing transcription of adpA. Two AdpA dimers then bind the upstream activation sequences of strR, approximately at nucleotide positions À270 and À50 with respect to the transcriptional start point of strR, and activate its transcription, as shown by Tomono and Tsai. 57) AdpA assists RNA polymerase in forming an open complex at an appropriate position for transcriptional initiation of strR, as determined by potassium permanganate footprinting. The pathway-specific transcriptional activator StrR induces transcription of all the streptomycin biosynthetic genes by binding multiple sites in the gene cluster, thus leading to biosynthesis of streptomycin from glucose. The major streptomycin resistance determinant, aphD, located downstream of strR, encoding streptomycin-6-phosphotransferase, is also transcribed by read-through from the A-factor-dependent strR promoter.
42) The co-transcription of strR and aphD accounts for the prompt induction of streptomycin resistance by A-factor and achieves a rapid increase in self-resistance just before induction of streptomycin biosynthesis.
II. The AfsK/AfsR/AfsS Regulatory System

Involvement of serine/threonine kinases in secondary metabolism
During my experiments 25 years ago, in which DNA fragments of S. coelicolor A3(2) were shotgun cloned in S. lividans TK21, I found a colony that produced a thick blue pigment in large amounts.
58) The pigment contained actinorhodin and undecylprodigiosin. These pigments are not produced by strain TK21 on routine agar medium, which implied that a gene introduced in S. lividans awakened ''sleeping'' antibiotic production genes.
59) The cloned gene, afsR, encoded a protein of 993 amino acids 60) whose N-terminal portion showed similarity to the pathway-specific transcriptional activators of Streptomyces, also known as SARP-family proteins (streptomycete antibiotic regulatory proteins). Subsequent studies by Hong 61) and Matsumoto 62) revealed that AfsR is phosphorylated on a threonine residue by a serine/threonine kinase AfsK (Fig. 4) . The AfsK-AfsR system was the first example of a functionally relevant serine/threonine phosphorylation system not only in the genus Streptomyces but also in the world of bacteria. AfsR is also phosphorylated by AfsL and PkaG. 63) AfsK self-activates its kinase activity by autophosphorylation at Thr-168. 64) On the other hand, Umeyama 65) found that KbpA binds the catalytic domain of the unphosphorylated form of AfsK and inhibits the autophosphorylation of AfsK by proteinprotein interaction. KbpA thus plays a role in a negative feedback system for AfsK-AfsR signal relay. All these findings show that AfsR serves as an integrator of intracellular and extracellular signals that are sensed by multiple serine/threonine kinases.
11)
Lee 66) identified afsS as a target of AfsR; the phosphorylated form of AfsR binds two direct repeat of 9 nucleotides, 5 0 -CGTTCATCG-3 0 and 5 0 -CGTTTATCT-3 0 , covering exactly the promoter region of afsS, and enhances its transcription. Because the promoter sequence is in many cases the site to which repressors bind, the mechanism by which AfsR activates afsS transcription involves an interesting aspect (see below). AfsS is a 63-amino-acid protein containing three repeats of the sequence Thr-X 2 -Asp-Asn-His-Met-Pro-X 2 -ProAla (X: non-conserved amino acids). Although the introduction of multicopies of afsS enhances production of actinorhodin and undecylprodigiosin by enhancing the transcription of actII-ORF4 and redD respectively, the way AfsS stimulates the transcription of these pathway-specific transcriptional activator genes remains to be elucidated. The afsK/afsR/afsS gene set is found in several Streptomyces spp., which suggests that this type of signal transduction via protein serine/threonine phosphorylation is common in this genus. The AfsKAfsR-AfsS signal relay exhibits more apparent phenotypic expression for secondary metabolism in S. coelicolor A3(2) and for aerial mycelium formation in S. griseus.
67)
Mechanism of transcriptional activation by the AfsR family proteins
As described above, the N-terminal portion of AfsR External and internal stimuli are sensed by serine/threonine kinases, AfsK, AfsL, and PkaG, and transferred to AfsR by means of phosphorylation of its Thr residue. These kinases activate their kinase activity by autophosphorylation of a single Thr residue, Thr-168 for AfsK, on sensing some stimulus. KbpA binds a non-phosphorylated form of AfsK and inhibits the autophosphorylation of AfsK, modulating the AfsK kinase activity by protein-protein interaction. The two phosphorylated AfsR monomers bind the same face of the DNA covering exactly the promoter region of afsS and dimerize upon binding. The AfsR dimer then recruits RNA polymerase (RNAP) on the opposite face of the DNA and forms a complex of DNA-(AfsR) 2 -RNAP competent for transcriptional initiation. The afsS product of 63 amino acids contains three repeats of 12 amino acids. AfsS activates secondary metabolism in an as yet unknown way. Reproduced in modified form from Lee et al. 66) belongs to the SARP family. Some SARP family members, such as ActII-ORF4 for actinorhodin production in S. coelicolor A3(2) 68) and DnrI for daunorubicin production in Streptomyces peucetius, 69) bind direct repeats covering the promoter elements of the respective targets, as does AfsR. Therefore, the manner of DNAbinding of AfsR and the mechanism of transcriptional activation by AfsR should hold true for SARP family members. We constructed AfsRÁC (from Met-1 to Ala-270), containing an OmpR-type DNA-binding domain, and found that, like the full-length AfsR, it binds direct repeats, one of which overlaps with the sequence corresponding to the À35 region of the afsS promoter, a target of AfsR. Tanaka and Takano found that two AfsRÁC monomers cooperatively form a ternary complex of DNA-(AfsRÁC) 2 -RNA polymerase (RNAP), although RNAP alone cannot bind the afsS promoter (Fig. 4) . The DNA-(AfsRÁC) 2 -RNAP complex is capable of transcriptional initiation both in vitro and in vivo. Mutant afsS promoters, having the distance between the AfsR-binding repeats and the À10 promoter element, still recruit RNAP and form an (AfsR) 2 -DNA-RNAP complex. However, deletion or addition of even a single nucleotide between the À10 element and the repeat sequence on the 3 0 side, leaving the AfsR-binding site intact, abolish the ability of the ternary complex to initiate transcription (A. Tanaka et al., manuscript in preparation). We assume that the RNAP in the (AfsR) 2 -DNA-RNAP complex formed on the intact afsS promoter is capable of making a contact with the À10 element, thus initiating the transcription. On the other hand, the RNAP in the ternary complex formed on the mutant afsS promoter cannot topologically make a stable contact with the À10 element. The same domain structure of AfsRÁC as SARPs and the same organization of their target sites suggest that SARP family members activate the transcription of their targets by recruiting RNAP to the respective promoter sites and forming a ternary DNA-(SARP) 2 -RNAP complex competent for transcriptional initiation.
III. Catalytic Properties of Enzymes Involved in Secondary Metabolism
A-factor switches on production of almost all secondary metabolites in S. griseus. Study of the A-factor regulatory cascade has inevitably driven us to identify the genes for secondary metabolite formation and to elucidate their catalytic functions. During the early stage of my study on the A-factor regulation, I noticed that the production of a yellow pigment and a brown melaninlike pigment was dependent on A-factor. Intensive study by Suzuki et al. 70, 71) of the yellow pigment, named grixazone, has revealed its biosynthesis pathway, which includes steps for novel, simple benzene ring formation and for phenoxazinone formation. Study by Funa et al. 72, 73) of the brown pigment has led us to the discovery of a novel melanin biosynthesis pathway that includes a type III polyketide synthase (PKS). I will briefly summarize the research on the A-factor-dependent pigments.
Grixazone biosynthesis pathway
The A-factor-dependent yellow pigment is produced under phosphate depletion, indicating that production of the pigment is also dependent on the phosphate concentration of the medium. 74 ) Therefore, the biosynthesis gene cluster of the pigment makes a good target to study the regulation of secondary metabolite formation not only by A-factor but also by phosphate. The whole gene cluster consists of 13 genes, among which the promoter of griR, the pathway-specific transcriptional activator, receives the signals of A-factor and the concentration of phosphate (our unpublished data).
Novel benzene ring biosynthesis. A combination of gene disruption and identification of compounds accumulated in disruptants showed that 3-amino-4-hydroxybenzoic acid (3,4-AHBA, Fig. 5 ) is an intermediate of grixazone. The shikimate pathway, including seven enzymatic steps for production of chorismate via shikimate from phosphoenolpyruvate and erythrose-4-phosphate, is common in various organisms for the biosynthesis not only of aromatic amino acids but also of most biogenic benzene derivatives. However, 3,4-AHBA turned out to be a benzene derivative that is biosynthesized by a novel, simple enzyme system. 71) Two genes, griI and griH, were found to be responsible for the biosynthesis of 3,4-AHBA; the two genes confer the in vivo production of 3,4-AHBA even on Escherichia coli. In vitro analysis showed that GriI catalyzes aldol condensation between two primary metabolites, L-aspartate-4-semialdehyde and dihydroxyacetone phosphate, to form a C 7 product, 2-amino-4,5-dihydroxy-6-one-heptanoic acid-7-phosphate, which is subsequently converted to 3,4-AHBA by GriH. This pathway is independent of the shikimate pathway, representing a novel, simple enzyme system responsible for the synthesis of a benzene ring from the C 3 and C 4 primary metabolites. griH homologs are found in the genomes of bacteria and higher plants, such as Arabidopsis thaliana and Oryza sativa, suggesting the possibility that the benzene ring biosynthetic pathway involving GriH homologs is distributed widely in nature.
Biosynthesis of a phenoxazinone chromophore. This pigment contains a phenoxazinone chromophore, suggesting that the gene cluster for grixazone biosynthesis should contain the genes encoding the enzymes responsible for its synthesis. Although several secondary metabolites containing a phenoxazinone skeleton, including actinomycin D, were isolated, no enzymes responsible for the biosynthesis of a phenoxazinone were known. griE and griF were identified by Suzuki et al. 70) GriE activates GriF by transferring copper ions to GriF, as is observed for a Streptomyces melanogenesis system in which MelC1 copper chaperon transfers two Cu ions to MelC2 tyrosinase. Despite the significant similarity of GriF to the tyrosinases, GriF shows no monophenolase activity, but oxidizes various o-aminophenols as substrates preferable to catechol-type substrates. Deletion of the griEF locus on the chromosome resulted in accumulation of 3-amino-4-hydroxybenzaldehyde (3,4-AHBAL), which suggested that the substrate of GriF was 3,4-AHBAL. 3,4-AHBA appears to be reduced by the action of GriC and GriD in an ATPdependent way to form 3,4-AHBAL. Consistently with this, GriF oxidizes 3,4-AHBAL to yield an o-quinone imine derivative, which is then non-enzymatically coupled with another molecule of o-quinone imine to form a phenoxazinone. The co-existence of N-acetylcysteine in the in vitro oxidation of 3,4-AHBAL by GriF results in the formation of grixazone A, which suggests that the -SH group of N-acetylcysteine is conjugated to the o-quinone imine formed from 3,4-AHBAL. The conjugate is presumably coupled with another molecule Top: A-factor and the phosphate concentration of the medium control the transcription of the whole grixazone biosynthesis gene cluster, which consists of 13 genes, from griA to griS, by transferring their signals to the promoter of griR, the pathway-specific transcriptional activator gene. GriR then activates the two transcriptional units, griCDEFG and griJIH, covering all the biosynthesis enzymes. griAB appears to encode an exporter, perhaps serving as a resistance determinant. Bottom: The grixazone biosynthesis route. 70, 71) Chemically rationalized routes for the reactions for GriIH, GriCD, and GriEF are shown. GriI catalyzes aldol condensation between the aldehyde carbon of aspartate-4-semialdehyde and the hydroxylated carbon of dihydroxyacetone phosphate to yield the condensed product, which is then converted to 3,4-AHBA by GriH. The catalysis pathway for GriH in the inset is our proposal. The carboxyl group of 3,4-AHBA is reduced in an ATP-dependent way by GriCD to form 3,4-AHBAL, which is then coupled by GriEF in the presence of N-acetylcysteine, resulting in grixazone A. GriE is a copper chaperon for GriF. Grixazone A is oxidized by an oxidase to yield grixazone B.
of the o-quinone imine (Fig. 5) . GriF is thus a novel oaminophenol oxidase that is responsible for the formation of the phenoxazinone chromophore in the grixazone biosynthesis pathway.
We have identified the whole biosynthesis pathway of grixazone, which includes the novel benzene ring and phenoxazinone chromophore formation. griA and griB are perhaps involved in the transport of grixazone. The biosynthesis gene cluster contains griR, the pathwayspecific transcriptional activator, to which the A-factor signal and the phosphate signal are transferred (our unpublished data). griS and griT in the cluster are probably regulators. Their functions remain to be elucidated.
Type III polyketide synthases in bacteria
Type III PKSs in Streptomyces. rppA encoding a chalcone synthase-like protein was cloned from S. griseus as a gene that conferred melanin-like pigment production on Streptomyces and E. coli. The pigment production was A-factor dependent in S. griseus. Funa et al. 72) identified the catalytic function of RppA and found that it selects malonyl-CoA as the starter, carries out four successive extensions and releases the resulting pentaketide to cyclize to 1,3,6,8-tetrahydroxynaphthalene (THN) (Fig. 6) . THN auto-oxidizes to form flaviolin, a red-brown pigment. The THN formed by RppA serves as an intermediate in the biosynthesis pathway not only for melanins but also for various secondary metabolites containing a naphthoquinone ring. For example, the THN formed by the action of RppA is converted to 1,4,6,7,9,12-hexahydroxyperylene-3,10-quinone (HPQ) by oxidative biaryl coupling catalyzed by P-450mel. 75) HPQ readily autopolymerizes to form HPQ melanin. A vivid contrast in THN melanin biosynthesis between streptomycetes and fungi is that the THN synthesized by the action of a type III PKS is used directly for condensation in the former, whereas the THN synthesized by the action of type I PKSs is first reduced, and the resulting 1,8-dihydroxynaphthalene is then condensed in the latter. In various streptomycetes, on the other hand, the THN synthesized by RppA is monooxygenated by the action of MomA, belonging to the ''cupin'' superfamily, to form flaviolin. 76) The flaviolin is further modified to give spore pigments in many streptomycetes.
Phenolic lipid synthesis by type III PKS in Azotobacter. Our discovery of RppA has established the idea that type III PKSs are distributed widely in bacteria. Cysts of the Gram-negative, nitrogen-fixing soil bacterium Azotobacter vinelandii are resting cells surrounded by a protective coat that confers resistance to various chemical and physical stresses. The major chemical components of the cyst coat are alkylresorcinols, amphiphilic molecules possessing an aromatic ring with a long aliphatic carbon chain. The genome database predicted the presence of an operon consisting of four genes, two of which encode a type III PKS, named ArsB and ArsC. In vitro experiments by Funa and Ozawa 77) revealed that ArsB and ArsC, sharing 71% amino acid sequence identity, are an alkylresorcinol synthase and an alkylpyrone synthase respectively (Fig. 6) . The alkylresorcinols are essential for encystment because the lack of alkylresorcinols synthesis caused by ars mutations results in the formation of severely impaired cysts, as observed by electron microscopy. Alkylresorcinol for- A, A homodimer of RppA catalyzes the four successive extensions of malonyl-CoA, starting with malonyl-CoA, and releases the resulting pentaketide to cyclize to THN.
72) The THN formed is oxidatively biaryl coupled to yield HPQ by the action of P-450mel. 75) HPQ readily autopolymerizes to form HPQ melanin. B, ArsB and ArsC accept the acyl-CoA as the starter substrate and cyclize the resultant tetraketide intermediates to yield an alkylresorcinol and an alkylpyrone respectively. 77) mation by a type III PKS has been found also in S. griseus and the fungus Neurospora crassa (our unpublished data).
IV. Combinatorial Biosynthesis of Flavonoids and Isoflavone
The presence of a chalcone synthase-like enzyme in Streptomyces, the key enzyme for the biosynthesis of a variety of flavonoid compounds in plants, gave me the idea that we might be able to produce plant-specific flavonoids by assembling genes required for their biosynthesis in bacteria. Once we produce flavonoids in bacteria, we should be able to modify the flavonoids further to yield various flavonoids, including unnatural compounds and isoflavones, by well-established techniques of fermentation and gene manipulation. 78) Flavonoid-derived compounds have received much attention due to their use as health-promoting components of the human diet for their cancer chemopreventive, antioxidant, and antiasthmatic activities.
1. Fermentative production of natural and unnatural flavonoids and stilbenes Natural flavonoids. In plants, phenylalanine ammonia-lyase (PAL), which deaminates phenylalanine to yield cinnamic acid, is the first enzyme in the general phenylpropanoid pathway (Fig. 7) . Cinnamic acid is hydroxylated by cinnamate 4-hydroxylase (C4H) to 4-coumaric acid, which is then activated to 4-coumaroylCoA by the action of 4-coumarate:CoA ligase (4CL). Chalcone synthase (CHS), which belongs to the type III polyketide synthase family, catalyzes the stepwise condensation of three acetate units from malonyl-CoA to yield naringenin chalcone, the precursor of a large number of flavonoids. Naringenin chalcone is converted to (2S)-naringenin by the action of chalcone isomerase (CHI). Naringenin is further modified to flavones, flavonols, and isoflavone, for example.
During the course of assembling the genes, Kaneko et al. 79) found from S. coelicolor A3(2) a cinnamate/ coumarate:CoA ligase (ScCCL) that attaches CoA to both cinnamate and coumarate at almost the same efficiency. When this gene is used as a member of the artificial gene cluster designed for the fermentative production of naringenin, one would expect that naringenin is produced from tyrosine and pinocembrin is produced from phenylalanine. The gene cluster we constructed on a high-copy-number plasmid involves PAL from the yeast Rhodotorula rubra, ScCCL from S. coelicolor A3(2), CHS from a licorice plant Glycyrrhiza echinata, and CHI from the Pueraria plant, all of which are under the control of the T7 promoter and a synthetic ribosome-binding sequence. Because the intracellular pool of malonyl-CoA is extremely small, we also constructed a plasmid in which the two subunit genes of acetyl-CoA carboxylase, catalyzing the conversion of acetyl-CoA to malonyl-CoA, from Corynebacterium glutamicum, are under the control of the T7 promoter and the ribosome-binding sequence. Under cultural conditions under which the E. coli cells harboring the two plasmids at a cell density of 50 g/l were incubated in the presence of 3 mM tyrosine or phenylalanine, the yields of naringenin and pinocembrin reached about 60 mg/l (Fig. 7) . 80, 81) Further introduction of the flavone synthase gene from Petroselinum crispum under the control of the T7 promoter caused the E. coli cells to produce flavones: 13 mg/l of apigenin from tyrosine and 9.4 mg/l of chrysin from phenylalanine. Introduction into the E. coli cells of the flavanones 3-hydroxylase and flavonol synthase genes from the plant Citrus led to production of flavonols: 15.1 mg/l of kaempferol from tyrosine and 1.1 mg/l of galangin from phenylalanine. 82) In addition to scale, cost, fermentation period, one of the advantages in production of plant-derived polyketide compounds in E. coli is that a single species of flavonoids and stilbenes is produced in a buffer (minimal medium) containing substrates, glucose, and an inducer of the promoters, which allows one easily to purify polyketide compounds from the buffer. Hence the E. coli cell containing artificial biosynthesis gene clusters is called an enzyme bag. It converts the substrate into a target polyketide in a buffer.
Unnatural flavonoids and stilbenes. We divided the flavonoid biosynthesis pathway into three steps: substrate synthesis, polyketide synthesis, and a modification step. For the substrate synthesis step, various carboxylic acids are converted to the corresponding CoA esters by CoA ligases. The CoA esters can be replaced by chemically synthesized N-acetylcysteamine (NAC) derivatives. For the polyketide synthesis step, one can use CHSs showing different times of condensation and different modes of cyclization. Instead of CHSs, stilbene synthases, showing a different mode of cyclization from those by CHSs, can also be used for this step. For the final modification step, flavone synthases, flavonol synthases, and other flavonoid-and stilbene-modifying enzymes of various origins are used. When one uses x kinds of CoA substrates, y kinds of chalcone and stilbene synthases, and z kinds of modification enzymes, it is to be expected that (x Â y Â z) kinds of unnatural flavonoids and stilbenes can be produced. In fact, Funa and Katsuyama have produced more than 60 unnatural flavonoid compounds so far (manuscript submitted).
2. One-pot synthesis of isoflavone from tyrosine Isoflavonoids, synthesized predominately in soybeans and other leguminous plants, have several beneficial effects on human health, such as chemopreventive actions against cancer, osteoporosis, cardiovascular disease. Genistein, a common precursor of the biosynthesis of isoflavonoids, has attracted much attention due to its phytoestrogen activity. Katsuyama et al. 83) constructed a system in which E. coli cells producing naringenin and yeast Saccharomyces cerevisiae cells carrying the isoflavone synthase gene from G. echinata are co-incubated (Fig. 7) . In other words, the E. coli cell is an enzyme bag that converts tyrosine to naringenin, and the yeast cell is an enzyme bag that converts the naringenin produced by the E. coli cell to genistein. Co-incubation of E. coli cells and S. cerevisiae cells in a medium containing 3 mM (543 mg/l) of tyrosine as the starting substrate yielded about 6 mg/l of genistein in the broth.
V. Future Perspectives
Elucidation of the regulation by -butyrolactones and serine/threonine kinases is important not only for the biology of the filamentous bacterial genus Streptomyces but also for the practical use of this genus in the production of useful secondary metabolites. Sequencing of the S. griseus genome has been completed in this laboratory (Y. Ohnishi et al., manuscript in preparation). Comprehensive study employing DNA microarray techniques, proteomics, and metabolomics should enable us to depict overall, precise pictures of the A-factor regulatory cascade and the network of protein phosphorylation. Comparative genomics by use of the genome sequences of S. coelicolor A3(2) and S. avermitilis helps us to understand the bacterium S. griseus and to mine and polish its treasure. Even between S. griseus and S. coelicolor A3(2), the signaling pathways for early developmental events and the genes for secondary metabolite formation are different. 84) Some genes for secondary metabolite formation are speciesspecific, but many genes differ from strain to strain. Mining and polishing useful genes for practical purposes is important, and at the same time, awakening of ''sleeping'' genes by various approaches is also important. Genome projects for actinomycetes, such as Actinoplanes, Kitasatospora, and Micromonospora, showing more complex morphology than Streptomyces, in Japan should contribute further to our understanding of the boundary microorganisms. . Plasmid 4GS contains the four enzyme genes under the control of the T7 promoter and a synthetic ribosome-binding sequence for the production of naringenin from tyrosine and of pinocembrin from phenylalanine. 81) To increase the intracellular pool of malonyl-CoA, acetyl-CoA carboxylase (ACC) genes, dtsR1 and accBC, from C. glutamicum, are placed on a plasmid. The plasmids carrying FNS and F3H/FLS are for modification of flavanones into flavones and flavonols respectively. B, The E. coli cells producing naringenin are co-incubated with the S. cerevisiae cells carrying IFS in the presence of tyrosine. The naringenin produced by E. coli is excreted from the cell, incorporated into the yeast cell, modified into an isoflavone (genistein), and finally excreted into the medium. 83) In addition to -butyrolactones, possible autoregulatory factors in Streptomyces species that are involved in secondary metabolism and morphological differentiation have been reported, although most of these are not precisely defined as autoregulators due to a shortage of genetic studies. 2, 3) The following two compounds can be termed regulators: B-factor (3 0 -butylphosphoryl AMP) at a few nM concentration controls rifamycin biosynthesis in Nocardia mediterranei, 85) and PI factor [pimaricin inducer; 2,3-diamino-2,3-bis(hydroxymethyl)-1,4-butanediol] at a few hundred nM induces the production of a macrolide, pimaricin, in Streptomyces natalensis.
86) It is conceivable that during evolution Streptomyces spp. have employed various chemical substances as autoregulators to control their own secondary metabolism and morphogenesis. The autoregulators must have evolved concomitantly with their specific receptors. Future studies might reveal chemical substances as novel autoregulators, together with their specific receptors.
A Streptomyces cell is a useful enzyme bag for the production of complex compounds by means of metabolic engineering and combinatorial biosynthesis, because it contains transport systems for a variety of compounds and it is resistant to a variety of the substances to be produced. During our experiments on the production of intermediates for medicines by bioconversion, we noticed that successful dioxygenation of benzoic acid derivatives by a hydroxylating enzyme in Streptomyces is due partly to its ability to transport the substrate and product through the membrane; the conversion does not proceed in E. coli due to lack of a transport system. 87) Our success in fermentative production of flavonoid compounds in E. coli indicates one of the future directions in applied microbiology. Streptomyces should become a useful host for production of more complex, non-bacterial compounds by a similar procedure. For efficient production, it is important to feed back knowledge of the regulation of primary and secondary metabolism to the architecture of artificial gene clusters and the mode of assembling genes.
